However, to confirm that changes in Vimentin and E-cadherin expression were via direct regulation by ZEB2 and not by direct interactions with FOXP3 or miR-155, we then depleted the breast cancer cells of ZEB1 or ZEB2 using siRNAs. The gene discussed is ZEB1; the disease is breast carcinoma.